Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011486

Chief Scientific Officer gave up 876 shares (to pay taxes)

  • Chief Scientific Officer acquired 2,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Scott · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-16 Exercise or conversion : show line 1 in the form +2,750 27,387 D
2019-02-19 Shares withheld for taxes : show line 2 in the form −876 $58.03 $50,834 26,511 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-16 Exercise or conversion : show line 3 in the form Restricted stock units −2,750 5,500 D
Loading xslF345X03/doc4.xml…